Arch Therapeutics, Inc. — Form D
Arch Therapeutics, Inc. of FRAMINGHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-07-08. The offering totals $7.3M, of which $7.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-07-08
- Form: D
- Accession: 0001144204-13-038441
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $7.3M
- Amount sold: $7.3M
- Investors: 58
- Date of first sale: 2013-06-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-199126
Issuer
- Name: Arch Therapeutics, Inc.
- CIK: 0001537561
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2009
- Address: 235 WALNUT STREET, SUITE 6, FRAMINGHAM, MA, 01702
- Phone: 617-431-2313
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| AVTAR W DHILLON | Director | CAMBRIDGE, MA |
| TERRENCE W NORCHI | Director | CAMBRIDGE, MA |
| ARTHUR W ROSENTHAL | Director | CAMBRIDGE, MA |
| ALAN W BARBER | Executive Officer | CAMBRIDGE, MA |
| TERRENCE W NORCHI | Executive Officer | CAMBRIDGE, MA |
| Richard Davis | Executive Officer | Greenville, SC |
| Guy W Fish | Director | Framingham, MA |
| Laurence W Hicks | Director | Framingham, MA |
| Daniel M Yrigoyen | Executive Officer | Framingham, MA |
| Punit W Dhillon | Director | Framingham, MA |
| Richard E Davis | Executive Officer | Framingham, MA |
| James R Sulat | Director | Framingham, MA |
| William Cotter | Executive Officer | Media, PA |
| Avtar Dhillon | Director | San Diego, CA |
| Terrence Norchi | Director | Wellesley, MA |
| Terrence Norchi | Executive Officer | Wellesley, MA |
| Arthur Rosenthal | Director | Wellesley, MA |
| Norchi Terrence | Director | Wellesley, MA |
| Norchi Terrence | Executive Officer | Wellesley, MA |
| Alan Barber | Executive Officer | Wellesley, MA |
| Michael S Abrams | Executive Officer | Sherborn, MA |
Other filings by this issuer (6)
More